REGISTERED
on 28 Apr 2020
Last Applicant/ Owned by
2200 Pennsylvania Ave. NW
Washington
DC
20037
Serial Number
88366693 filed on 01st Apr 2019
Registration Number
6040230 registered on 28th Apr 2020
Filing Basis
1. intent to use
2. use application currently
Disclaimer
NO DATA
HETLIOZ (TASIMELTEON) CAPSULES
Pharmaceutical preparations, containing tasimelteon, for use in the treatment of circadian rhythm diseases and disorders; and pharmaceutical preparations, containing tasimelteon, for use in the treatment of non-24 hour sleep-wake disorder
Classification Information
Class [005]
Pharmaceutical Products
Pharmaceutical preparations, containing tasimelteon, for use in the treatment of circadian rhythm diseases and disorders; and pharmaceutical preparations, containing tasimelteon, for use in the treatment of non-24 hour sleep-wake disorder
First Use Date in General
15th Apr 2014
First Use Date in Commerce
15th Apr 2014
Mark Details
Serial Number
No 88366693
Mark Type
No Service/Collective Mark
Attorney Docket Number
No VAND-0129US2
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Design Code(s)
26.01.21 -
Circles that are totally or partially shaded
Legal History
| Status Date | Action Taken |
|---|---|
| 28th Apr 2020 | REGISTERED-PRINCIPAL REGISTER |
| 25th Mar 2020 | 1(B) BASIS DELETED; PROCEED TO REGISTRATION |
| 25th Mar 2020 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| 03rd Mar 2020 | NOTICE OF ALLOWANCE CANCELLED |
| 03rd Mar 2020 | TEAS POST PUBLICATION AMENDMENT RECEIVED |
| 10th Sep 2019 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| 16th Jul 2019 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 16th Jul 2019 | PUBLISHED FOR OPPOSITION |
| 26th Jun 2019 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| 12th Jun 2019 | APPROVED FOR PUB - PRINCIPAL REGISTER |